Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey

Author:

Jimenez Adrian E.1,Cicalese Kyle V.2,Jimenez Miguel A.3,Chakravarti Sachiv4,Kuo Cathleen C.5,Lozinsky Shannon6,Schwab Joseph H.7,Knowlton Sasha E.8,Rowan Nicholas R.9,Mukherjee Debraj4

Affiliation:

1. Department of Neurosurgery, Columbia University Medical Center, New York, New York;

2. Department of Neurosurgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia;

3. Department of Neurosurgery, The University of Chicago Pritzker School of Medicine, Chicago, Illinois;

4. Departments of Neurosurgery and

5. Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences at University at Buffalo, New York;

6. Chordoma Foundation, Durham, North Carolina;

7. Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and

8. Department of Physical Medicine and Rehabilitation, University of North Carolina School of Medicine, Chapel Hill, North Carolina

9. Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland;

Abstract

OBJECTIVE Chordomas are rare malignant bone tumors whose location in the skull base or spine, invasive surgical treatment, and accompanying adjuvant radiotherapy may all lead patients to experience poor quality of life (QOL). Limited research has been conducted on specific demographic and clinical factors associated with decreased QOL in chordoma survivors. Thus, the aim of the present study was to investigate several potential variables and their impact on specific QOL domains in these patients as well the frequencies of specific QOL challenges within these domains. METHODS The Chordoma Foundation (CF) Survivorship Survey was electronically distributed to chordoma survivors subscribed to the CF Chordoma Connections forum. Survey questions assessed QOL in three domains: physical, emotional/cognitive, and social. The degree of impairment was assessed by grouping the participants into high- and low-challenge groups designated by having ≥ 5 or < 5 symptoms or challenges within a given QOL domain. Bivariate analysis of demographic and clinical characteristics between these groups was conducted using Fisher’s exact test and the Mann-Whitney U-test. RESULTS A total of 665 chordoma survivors at least partially completed the survey. On bivariate analysis, female sex was significantly associated with increased odds of significant emotional (p = 0.001) and social (p = 0.019) QOL burden. Younger survivors (age < 65 years) were significantly more likely to experience significant physical (p < 0.0001), emotional (p < 0.0001), and social (p < 0.0001) QOL burden. Skull base chordoma survivors had significantly higher emotional/cognitive QOL burden than spinal chordoma survivors (p = 0.022), while the converse was true for social QOL challenges (p = 0.0048). Survivors currently in treatment were significantly more likely to experience significant physical QOL challenges compared with survivors who completed their treatment > 10 years ago (p = 0.0074). Fear of cancer recurrence (FCR) was the most commonly reported emotional/cognitive QOL challenge (49.6%). Only 41% of the participants reported having their needs met for their physical QOL challenges as well as 25% for emotional/cognitive and 18% for social. CONCLUSIONS The authors’ findings suggest that younger survivors, female survivors, and survivors currently undergoing treatment for chordoma are at high risk for adverse QOL outcomes. Additionally, although nearly half of the participants reported a FCR, very few reported having adequate emotional/cognitive care. These findings may be useful in identifying specific groups of chordoma survivors vulnerable to QOL challenges and bring to light the need to expand care to meet the QOL needs for these patients.

Publisher

Journal of Neurosurgery Publishing Group (JNSPG)

Reference32 articles.

1. Chordoma—current understanding and modern treatment paradigms;Barber SM,2021

2. Chordoma;Tenny S,2022

3. Chordoma: current concepts, management, and future directions;Walcott BP,2012

4. Descriptive epidemiology of chordomas in the United States;Das P,2020

5. The biological basis for modern treatment of chordoma;Diaz RJ,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3